Currently, ProKidney Corp [PROK] is trading at $3.73, up 515.00%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The PROK shares have gain 529.96% over the last week, with a monthly amount glided 373.95%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
ProKidney Corp [NASDAQ: PROK] stock has seen the most recent analyst activity on June 30, 2025, when BofA Securities downgraded its rating to a Underperform but kept the price target unchanged to $1 for it. On September 10, 2024, Guggenheim initiated with a Buy rating and assigned a price target of $6 on the stock. BofA Securities downgraded its rating to a Neutral. BTIG Research started tracking with a Buy rating for this stock on July 25, 2023, and assigned it a price target of $16. In a note dated December 21, 2022, Jefferies initiated an Buy rating and provided a target price of $15 on this stock.
This stock has fluctuated between a low of $0.46 and a high of $2.59 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $4.67 within the next 12 months. ProKidney Corp [NASDAQ: PROK] shares were valued at $3.73 at the most recent close of the market. An investor can expect a potential return of 25.2% based on the average PROK price forecast.
Analyzing the PROK fundamentals
Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -604.54%, Pretax Profit Margin comes in at -542.68%, and Net Profit Margin reading is -223.62%. To continue investigating profitability, this company’s Return on Assets is posted at -0.17, Equity is 0.07 and Total Capital is -0.5. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. However, for the 1st resistance point, the stock is sitting at 5.4300, and for the 2nd resistance point, it is at 7.1200.
Ratios To Look Out For
To put it in perspective, the Current Ratio for ProKidney Corp [NASDAQ:PROK] is 10.96. Also, the Quick Ratio is 10.96, while the Cash Ratio stands at 2.98. Considering the valuation of this stock, the price to sales ratio is 3521.79.
Transactions by insiders
Recent insider trading involved DARIN J WEBER, Officer, that happened on Jul 08 ’25 when 0.1 million shares were purchased. Add’l Rep. Persons-see Ex.99-1, Control Empresarial de Capital completed a deal on Apr 22 ’25 to buy 0.39 million shares. Meanwhile, Add’l Rep. Persons-see Ex.99-1 Control Empresarial de Capital bought 25000.0 shares on Apr 17 ’25.
